Sanara Medtech Share Price Today
(NASDAQ: SMTI)

Name: Sanara Medtech Share Price Today (NASDAQ: SMTI) - Sanara Medtech Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Sanara Medtech share price is $32.98 & ₹2,868.24 as on 6 Mar 2025, 2.30 'hrs' IST

$32.98

▲

1.09

(3.42%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Sanara Medtech share price in Dollar and Rupees. Guide to invest in Sanara Medtech stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Sanara Medtech, along with analyst recommendations, forecasts, and comprehensive financials.

Sanara Medtech share price movements

Today's Low: $32.71
Today's High: $33.33
$32.98
0.82%
Downside
Day's Volatility :1.85%
Upside
1.04%
52 Weeks Low: $26.00
52 Weeks High: $39.08
$32.98
21.16%
Downside
52 Weeks Volatility :33.47%
Upside
15.61%

Sanara Medtech (SMTI) Returns

Period	Sanara Medtech Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-6.65%	3.7%	0.0%
6 Months	-5.88%	-2.8%	0.0%
1 Year	-10.36%	2.5%	0.0%
3 Years	34.61%	12.9%	-11.6%

Sanara Medtech (SMTI) Key Statistics

in dollars & INR

Previous Close	$31.89
Open	$32.0
Today's High	$33.3265
Today's Low	$32.71
Market Capitalization	$278.8M
Today's Volume	$15.7K
52 Week High	$39.08
52 Week Low	$26.0
Revenue TTM	$78.1M
EBITDA	$-2.3M
Earnings Per Share (EPS)	$-0.97
Profit Margin	-10.71%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-20.28%

How to invest in Sanara Medtech Stock (SMTI) from India?

It is very easy for Indian residents to invest directly in Sanara Medtech from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Sanara Medtech stock in both Indian Rupees (INR) and US Dollars (USD). Search for Sanara Medtech or SMTI on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Sanara Medtech or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Sanara Medtech shares which would translate to 0.026 fractional shares of Sanara Medtech as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Sanara Medtech, in just a few clicks!

Returns in Sanara Medtech (SMTI) for Indian investors in Rupees

The Sanara Medtech stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Sanara Medtech investment value today

Current value as on today

₹94,593

Returns

₹5,407

(-5.41%)

Returns from Sanara Medtech Stock

₹10,356 (-10.36%)

Dollar Returns

₹4,949 (+4.95%)

Indian investors sentiment towards Sanara Medtech (SMTI)

-11%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Sanara Medtech Stock from India on INDmoney has decreased by -11% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Sanara Medtech

BlackRock Inc
2.46%
Vanguard Group Inc
2.30%
Geode Capital Management, LLC
1.01%
State Street Corp
0.73%
Northern Trust Corp
0.47%
Renaissance Technologies Corp
0.41%

Analyst Recommendation on Sanara Medtech

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Sanara Medtech(by analysts ranked 0 to 5 stars)

Based on 7 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Sanara Medtech Stock (SMTI)

What analysts predicted

Upside of 45.54%

Target:

$48.00

Current:

$32.98

Insights on Sanara Medtech Stock (Ticker Symbol: SMTI)

Price Movement
In the last 7 days, SMTI stock has moved down by -4.0%
Increasing Revenue
Revenue is up for the last 13 quarters, 5.82M → 21.67M (in $), with an average increase of 10.1% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -3.50M → -2.85M (in $), with an average increase of 22.6% per quarter
SMTI vs ISRG (1 yr)
In the last 1 year, Intuitive Surgical, Inc. has given 46.3% return, outperforming this stock by 56.7%
SMTI vs ISRG (3 yr)
In the last 3 years, Intuitive Surgical, Inc. has given 87.9% return, outperforming this stock by 58.1%
Price to Sales
ForSMTI every $1 of sales, investors are willing to pay $3.6, whereas for Intuitive Surgical, Inc., the investors are paying $24.2 for every $1 of sales.

SMTI Sanara Medtech Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$5.8M	↓ 7.41%
Net Income	$-600.6K	↓ 281.27%
Net Profit Margin	-10.29%	↓ 15.54%

	FY19	Y/Y Change
Revenue	$11.8M	↑ 101.56%
Net Income	$-2.9M	↑ 387.9%
Net Profit Margin	-24.9%	↓ 14.61%

	FY20	Y/Y Change
Revenue	$15.6M	↑ 32.47%
Net Income	$-4.4M	↑ 49.57%
Net Profit Margin	-28.12%	↓ 3.22%

	FY21	Y/Y Change
Revenue	$24.1M	↑ 54.9%
Net Income	$-7.3M	↑ 66.69%
Net Profit Margin	-30.26%	↓ 2.14%

	FY22	Y/Y Change
Revenue	$45.8M	↑ 89.87%
Net Income	$-8.1M	↑ 10.77%
Net Profit Margin	-17.65%	↑ 12.61%

	FY23	Y/Y Change
Revenue	$65.0M	↑ 41.77%
Net Income	$-4.3M	↓ 46.82%
Net Profit Margin	-6.62%	↑ 11.03%

	Q2 FY23	Q/Q Change
Revenue	$15.8M	↑ 1.49%
Net Income	$-1.8M	↑ 21.52%
Net Profit Margin	-11.6%	↓ 1.91%

	Q3 FY23	Q/Q Change
Revenue	$16.0M	↑ 1.73%
Net Income	$-1.1M	↓ 41.98%
Net Profit Margin	-6.62%	↑ 4.98%

	Q4 FY23	Q/Q Change
Revenue	$17.7M	↑ 10.39%
Net Income	$-237.2K	↓ 77.63%
Net Profit Margin	-1.34%	↑ 5.28%

	Q1 FY24	Q/Q Change
Revenue	$18.5M	↑ 4.79%
Net Income	$-1.8M	↑ 643.77%
Net Profit Margin	-9.52%	↓ 8.18%

	Q2 FY24	Q/Q Change
Revenue	$20.2M	↑ 8.75%
Net Income	$-3.5M	↑ 98.62%
Net Profit Margin	-17.38%	↓ 7.86%

	Q3 FY24	Q/Q Change
Revenue	$21.7M	↑ 7.5%
Net Income	$-2.9M	↓ 18.44%
Net Profit Margin	-13.19%	↑ 4.19%

	FY18	Y/Y Change
Profit	$5.3M	↓ 3.06%

	FY19	Y/Y Change
Profit	$10.6M	↑ 98.06%

	FY20	Y/Y Change
Profit	$14.0M	↑ 32.33%

	FY21	Y/Y Change
Profit	$21.8M	↑ 56.28%

	FY22	Y/Y Change
Profit	$39.5M	↑ 80.84%

	FY23	Y/Y Change
Profit	$57.1M	↑ 44.72%

	Q2 FY23	Q/Q Change
Profit	$13.6M	↑ 1.26%

	Q3 FY23	Q/Q Change
Profit	$14.3M	↑ 5.22%

	Q4 FY23	Q/Q Change
Profit	$14.8M	↑ 3.74%

	Q1 FY24	Q/Q Change
Profit	$15.5M	↑ 4.96%

	Q2 FY24	Q/Q Change
Profit	$18.2M	↑ 16.79%

	Q3 FY24	Q/Q Change
Profit	$19.7M	↑ 8.43%

	FY18	Y/Y Change
Operating Cash Flow	$277.1K	↓ 298.15%
Investing Cash Flow	$-27.8K	↓ 67.66%
Financing Cash Flow	$-208.1K	↑ 43.96%

	FY19	Y/Y Change
Operating Cash Flow	$-2.2M	↓ 882.05%
Investing Cash Flow	$-1.2M	↑ 4206.94%
Financing Cash Flow	$9.8M	↓ 4809.23%

	FY20	Y/Y Change
Operating Cash Flow	$-4.0M	↑ 86.15%
Investing Cash Flow	$-2.7M	↑ 129.46%
Financing Cash Flow	$622.3K	↓ 93.65%

	FY21	Y/Y Change
Operating Cash Flow	$-4.8M	↑ 19.33%
Investing Cash Flow	$-5.3M	↑ 92.57%
Financing Cash Flow	$28.3M	↑ 4446.9%

	FY22	Y/Y Change
Operating Cash Flow	$-5.6M	↑ 15.38%
Investing Cash Flow	$-3.5M	↓ 33.55%
Financing Cash Flow	$-627.3K	↓ 102.22%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-1.7M	↓ 1.23%
Investing Cash Flow	$-12.9K	↓ 52.15%
Financing Cash Flow	$506.6K	↑ 428.74%

Sanara Medtech Technicals Summary

Sell

Neutral

Buy

Sanara Medtech is currently in a neutral trading position according to technical analysis indicators.

Sanara Medtech (SMTI) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Sanara Medtech Inc	-7.05%	-5.88%	-10.36%	34.61%	-12.61%
Intuitive Surgical, Inc.	-2.01%	19.16%	46.34%	94.07%	233.7%
Alcon Ag	3.44%	0.33%	10.46%	30.15%	67.23%
Resmed Inc.	-6.92%	-8.56%	21.46%	-9.48%	44.87%
Becton, Dickinson And Company	-7.55%	-3.91%	-4.87%	-18.81%	-2.89%
Cooper Companies Inc., The	-4.17%	-14.24%	-10.35%	-8.95%	15.06%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Sanara Medtech Inc	NA	NA	NA	0.0	-0.2	-0.05	NA	4.55
Intuitive Surgical, Inc.	88.57	88.57	3.92	8.06	0.16	0.09	NA	46.08
Alcon Ag	45.84	45.84	2.88	3.26	0.05	0.03	0.0	43.58
Resmed Inc.	27.56	27.56	1.52	9.47	0.26	0.14	0.01	35.77
Becton, Dickinson And Company	38.47	38.47	1.04	14.42	0.07	0.04	0.02	87.78
Cooper Companies Inc., The	46.74	46.74	9.59	3.98	0.05	0.04	NA	40.5

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Sanara Medtech Inc	Buy	$278.8M	-12.61%	NA	-10.71%
Intuitive Surgical, Inc.	Buy	$199.0B	233.7%	88.57	27.81%
Alcon Ag	Buy	$45.8B	67.23%	45.84	10.27%
Resmed Inc.	Buy	$34.0B	44.87%	27.56	25.35%
Becton, Dickinson And Company	Buy	$64.4B	-2.89%	38.47	8.37%
Cooper Companies Inc., The	Buy	$18.1B	15.06%	46.74	10.07%

About Sanara Medtech

Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns; and HYCOL, a medical hydrolysate of Type I bovine collagen intended for the management of full and partial thickness wounds, including pressure ulcers, venous and arterial leg ulcers, and diabetic foot ulcers. It also provides BIAKOS Antimicrobial Skin and Wound Cleanser, a patented product that contains synergistic ingredients that have been shown to impact mature biofilm microbes; BIAKOS Antimicrobial Wound Gel, an antimicrobial hydrogel wound dressing that helps against planktonic microbes, as well as immature and mature biofilms; and BIAKOS Antimicrobial Skin and Wound Irrigation Solution. In addition, it develops BIASURGE, a no-rinse surgical solution used for wound irrigation; FORTIFY TRG, a freeze-dried, multi-layer small intestinal submucosa extracellular matrix sheet; FORTIFY FLOWABLE extracellular matrix, an advanced wound care device; TEXAGEN, a multi-layer amniotic membrane allograft used as an anatomical barrier with robust handling that can be sutured for securement; and VIM Amnion Matrix, a homologous wound covering product. Sanara MedTech Inc. was incorporated in 2001 and is based in Fort Worth, Texas.

Organization	Sanara Medtech
Employees	107
CEO	Mr. Ronald T. Nixon
Industry	Pharmaceuticals: Generic

Management People of Sanara Medtech

Name	Title
Mr. Ronald T. Nixon	Executive Chairman & CEO
Mr. Michael D. McNeil	Chief Accounting & Administrative Officer and Corporate Secretary
Ms. Elizabeth B. Taylor	Chief Financial Officer
Mr. Jacob A. Waldrop	Chief Operating Officer
Mr. Bill Fitzgerald	Chief Compliance Officer
Ms. Tricia Matteson	Vice President of Marketing
Mr. Tyler Palmer	Chief Corporate Development & Strategy Officer
Dr. Christopher A. Morrison FACHM, FAPWCA, FCCWS, M.D.	President of Telehealth Services
Dr. Rebecca Erin Mcmahon	President of Research & Development
Mr. Seth Yon	President of Commercial

Important FAQs about investing in SMTI Stock from India :

What is Sanara Medtech share price today?

Sanara Medtech share price today stands at $32.98, Open: $32.00 ; Previous Close: $31.89 ; High: $33.33 ; Low: $32.71 ; 52 Week High: $39.08 ; 52 Week Low: $26.00.

The stock opens at $32.00, after a previous close of $31.89. The stock reached a daily high of $33.33 and a low of $32.71, with a 52-week high of $39.08 and a 52-week low of $26.00.

Can Indians buy Sanara Medtech shares?

Yes, Indians can invest in the Sanara Medtech (SMTI) from India.

With INDmoney, you can buy Sanara Medtech at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Sanara Medtech at zero transaction cost.

How can I buy Sanara Medtech shares from India?

It is very easy to buy Sanara Medtech from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Sanara Medtech (SMTI) be purchased?

Yes, you can buy fractional shares of Sanara Medtech with INDmoney app.

What are the documents required to start investing in Sanara Medtech stocks?

To start investing in Sanara Medtech, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.